PG
AZN icon

Pendal Group’s AstraZeneca AZN Stock Holding History

Pendal Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$373K Sell
2,752
-11
-0.4% -$1.38K ﹤0.01% 407
2022
Q3 		$303K Sell
2,763
-25
-0.9% -$3.17K ﹤0.01% 391
2022
Q2 		$368K Sell
2,788
-3,644
-57% -$478K ﹤0.01% 388
2022
Q1 		$853K Sell
6,432
-240
-4% -$28.8K 0.01% 350
2021
Q4 		$777K Sell
6,672
-523
-7% -$61.5K 0.01% 371
2021
Q3 		$864K Buy
+7,195
New +$838K 0.01% 341

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pendal Group's AZN Position: Q4 2022 in Review

Pendal Group reduced its AstraZeneca (AZN) stake by 0.4% in Q4 2022, selling an estimated $1.38K and leaving 2,752 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Pendal Group first reported a position in AZN in Q3 2021 and has held it in 6 quarters since. The position peaked at $864K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • Pendal Group held 2,752 shares of AstraZeneca worth $373K as of Q4 2022.
  • Pendal Group sold 11 AstraZeneca shares in Q4 2022, an estimated $1.38K.
  • AstraZeneca made up ﹤0.01% of Pendal Group's portfolio in Q4 2022, its #407 holding.
  • Pendal Group first reported a position in AstraZeneca in Q3 2021 and has held it in 6 quarters since.
  • Pendal Group's AstraZeneca position peaked at $864K in Q3 2021.
  • 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.